References

1. Cono J; Cragan JD; Jamieson DJ. Prophylaxis and Treatment of Pregnant Women for Emerging Infections and Bioterrorism Emergencies. Emerg Infect Dis. 2006;12(11) ©2006 Centers for Disease Control and Prevention (CDC).
2. Cono J; Cragan JD; Jamieson DJ. Prophylaxis and Treatment of Pregnant Women for Emerging Infections and Bioterrorism Emergencies. Emerg Infect Dis. 2006;12(11) ©2006 Centers for Disease Control and Prevention (CDC).
3. Updated Interim Recommendations for the Use of Antiviral Medications in the Treatment and Prevention of Influenza for the 2009-2010 Season. Centers for Disease Control and Prevention. 9/8/09. www.cdc.gov/h1n1flu/recommendations.htm.
4. Rasmussen SA, Jamieson DA, MacFarlane K, Cragan JD, Williams J, Henderson Z: Pandemic influenza and pregnant women: summary of a meeting of experts. Am J Public Health. 2009 Jun 18.
5. Kadanali A, Tasyaran MA, Kadanali S. Anthrax during pregnancy: case reports and review. Clin Infect Dis. 2003 May 15;36(10):1343-6. Epub 2003 May 1.
6. Inglesby TV, MD; O’Toole T, Henderson DA, et al. Anthrax as a Biological Weapon, 2002 Updated Recommendations for Management. JAMA. 2002;287:2236-2252..
7. ACOG Committee on Obstetric Practice. American College of Obstetricians and Gynecologists. ACOG Committee Opinion number 268, February 2002. Management of asymptomatic pregnant or lactating women exposed to anthrax. Obstet Gynecol. 2002 Feb;99(2):366-8.
8. Wright JG, et al. Use of Anthrax Vaccine in the United States – Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR July 23, 2010 / 59(rr06);1-30. www.cdc.gov/mmwr/preview/mmwrhtml/rr5906a1.htm.
9. Arnon, SS, Schechter R, Inglesby TV, et al. Botulinum Toxin as a Biological Weapon, 2002 Updated Recommendations for Management. JAMA. 2001;285:1059-1070.
10. Arnon, SS, Schechter, Maslanka SE, et al. Human botulism immune globulin for the treatment of infant botulism. N Engl J Med. 2006 Feb 2;354(5):462-71.
11. Mupapa K, Mukundu W, Bwaka MA, et al. Ebola hemorrhagic fever and pregnancy. J Infect Dis. 1999 Feb;179 Suppl 1:S11-2.
12. Borio L, Inglesby T, MD; Peters CJ, et al. Hemorrhagic fever viruses as a Biological Weapon: Medical and Public Health Management. JAMA. 2002;287:2391-2405.
13. Roback JD. CMV and blood transfusions. Rev Med Virol. 2002 Jul-Aug;12(4):211-9.
14. Welty TK, Grabman J, Kompare E, et al. Nineteen Cases of Plague in Arizona A Spectrum Including Ecthyma Gangrenosum Due to Plague and Plague in Pregnancy. West J Med. 1985 May; 142(5): 641–646.
15. Inglesby TV, MD; Dennis DT, Henderson DA, et al. Plague as a Biological Weapon: Medical and Public Health Management. JAMA, 2000; 283: 2281-2290.
16. Nashiura H. Smallpox during pregnancy and maternal outcomes. Emerg Infect Dis. 2006 Jul;12(7):1119-21.
17. Jamieson DJ, Theiler RN, Rasmussen SA. Emerging Infections and Pregnancy. Emerg Infect Dis. 2006;12(11) ©2006 Centers for Disease Control and Prevention (CDC).
18. Henderson DA; Inglesby TV, Bartlett JG et al; Smallpox as Biological Weapon: Medical and Public Health Management. JAMA. 1999;281:2127-2137.
19. Dennis DT, Inglesby TV, et al; Tularemia as Biological Weapon: Medical and Public Health Management. JAMA. 2001;285:2763-2773.
20. Karlssen RL,Sterri S, Lyngaas S,et al: Reference values for erythrocyte acetylcholinesterase and plasma activities in children: Implications for organophosphate intoxications. Scand J Clin Lab Invest 1981; 4:301-302.
21. Organic phosphorus compounds–nerve agents. Barthold CL – Crit Care Clin – 01-OCT-2005; 21(4): 673-89, v-vi.
22. Sebe A, Satar S, Alpay R, et al. Organo­phosphate poisoning associated with fetal death: a case study. Mt Sinai J Med. 2005 Sep;72(5):354-6.
23. Kamha AA, Al Omary I, Zalabany HA, et al. Organophosphate Poisoning in Pregnancy: A Case Report. Basic Clin Pharmacol Toxicol. 96 (5), 397–398. doi:10.1111/j.1742-7843. 2005.pto_09.x.
24. Marks AR, Harley K, Bradman A, Kogut K, Barr DB, et al. Organophosphate Pesticide Exposure and Attention in Young Mexican-American Children: The CHAMACOS Study, 2010 Environ Health Perspect 118(12): doi:10.1289/ehp.1002056.
25. Perera FP, Rauh V, Whyatt RM, et al. Effect of prenatal exposure to airborne polycyclic aromatic hydrocarbons on neurodevelopment in the first 3 years of life among inner-city children. Environ Health Perspect. 2006 Aug;114(8):1287-92.
26. Eskenazi B, Harley K, Bradman A, et al. Association of in utero organophosphate pesticide exposure and fetal growth and length of gestation in an agricultural population. Environ Health Perspect. 2004 Jul;112(10):1116-24.
27. Sebe A, Satar S , et al. Organophosphate Poisoning. Associated with Fetal Death: A Case Study. Mount Sinai J Medicine. 2005; 72:354.
28. Lee EC. Clinical Manifestations of Sarin Nerve Gas Exposure. JAMA. 2003;290:659-662.
29. Prenatal Radiation Exposure: A Fact Sheet for Physicians. CDC. www.bt.cdc.gov/radiation/prenatalphysician.asp. Last modified March 23, 2005.
30. Emergency Preparedness & Response: Potassium Iodide (KI) . CDC. Last modified 10/11/06. www.bt.cdc.gov/radiation/ki.asp
31. Emergency Preparedness & Response: Facts About Neupogen®. CDC. Last modified 3/1/05. www.bt.cdc.gov/radiation/neupogenfacts.asp.
32. Emergency Preparedness & Response: Facts About DTPA . CDC. Last modified 10/11/06. www.bt.cdc.gov/radiation/dtpa.asp
33. Emergency Preparedness & Response: Prussian Blue. CDC. Last modified 8/17/05. www.bt.cdc.gov/radiation/prussianblue.asp.